Inventor · disambiguated record
Daniel A. Haber
Also filed as: HABER DANIEL · HABER DANIEL A · HABER DANIEL ARIE
36 granted patents·22 pending applications·869 citations·filing 1991–2025
97Inventor score
Files withMASSACHUSETTS GEN HOSPITAL26GEN HOSPITAL CORP5MASSACHUSETTS INST TECHNOLOGY5BATTELLE MEMORIAL INSTITUTE4BELL DAPHNE WINIFRED2
Top patents by PatentIndex Score
58 records- 0198US7964349B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsGEN HOSPITAL CORP·Filed 2007·Granted Jun 21, 2011·92 cites·31 claims
- 0298US7294468B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsGEN HOSPITAL CORP·Filed 2005·Granted Nov 13, 2007·187 cites·8 claims
- 0396US8465916B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsBELL DAPHNE WINIFRED·Filed 2007·Granted Jun 18, 2013·85 cites·21 claims
- 0496US8105769B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsBELL DAPHNE WINIFRED·Filed 2007·Granted Jan 31, 2012·97 cites·4 claims
- 0592US5350840ALocalization and characterization of the Wilms' tumor geneMASSACHUSETTS INST TECHNOLOGY·Filed 1991·Granted Sep 27, 1994·143 cites·8 claims
- 0689US9035036B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsGEN HOSPITAL CORP·Filed 2013·Granted May 19, 2015·8 cites·26 claims
- 0788US11898209B2Digital analysis of circulating tumor cells in blood samplesMASSACHUSETTS GEN HOSPITAL·Filed 2020·Granted Feb 13, 2024·2 cites·19 claims
- 0886US10140422B2Progression analytics systemBATTELLE MEMORIAL INSTITUTE·Filed 2015·Granted Nov 27, 2018·7 cites·23 claims
- 0986US5726288ALocalization and characterization of the Wilms' tumor geneMASSACHUSETTS INST TECHNOLOGY·Filed 1993·Granted Mar 10, 1998·57 cites·5 claims
- 1083US10872131B2Progression analytics systemBATTELLE MEMORIAL INSTITUTE·Filed 2018·Granted Dec 22, 2020·4 cites·20 claims
- 1183US10731162B2Methods relating to circulating tumor cell clusters and the treatment of cancerMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Aug 4, 2020·1 cites·11 claims
- 1283US6177248B1Downstream genes of tumor suppressor WT1AFFYMETRIX INC·Filed 1999·Granted Jan 23, 2001·103 cites·26 claims
- 1382US11371101B2Digital analysis of blood samples to determine efficacy of cancer therapies for specific cancersMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted Jun 28, 2022·2 cites·15 claims
- 1480US10596162B2Method for treating gefitinib resistant cancerWYETH LLC·Filed 2016·Granted Mar 24, 2020·3 cites·4 claims
- 1579US12152241B2Targeting human satellite II (HSATII)MASSACHUSETTS GEN HOSPITAL·Filed 2019·Granted Nov 26, 2024·1 cites·17 claims
- 1678US2024132969A1Digital Analysis of Circulating Tumor Cells in Blood SamplesMASSACHUSETTS GEN HOSPITAL·Filed 2023·Application pending·0 cites
- 1776US10053692B2Methods relating to circulating tumor cell clusters and the treatment of cancerMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Aug 21, 2018·2 cites·7 claims
- 1876US2024011035A1Methods relating to circulating tumor cell clusters and the treatment of cancerMASSACHUSETTS GEN HOSPITAL·Filed 2022·Application pending·0 cites
- 1975US12006555B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsMASSACHUSETTS GEN HOSPITAL·Filed 2020·Granted Jun 11, 2024·0 cites·16 claims
- 2075US9417244B2Cadherins as cancer biomarkersMASSACHUSETTS GEN HOSPITAL·Filed 2012·Granted Aug 16, 2016·2 cites·15 claims
- 2174US10603314B2Method for treating gefitinib resistant cancerHABER DANIEL A·Filed 2006·Granted Mar 31, 2020·3 cites·9 claims
- 2273US10669589B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Jun 2, 2020·0 cites·13 claims
- 2372US6316599B1Localization and characterization of the Wilms' tumor geneMASSACHUSETTS INST TECHNOLOGY·Filed 1998·Granted Nov 13, 2001·29 cites·10 claims
- 2471US11421233B2Methods relating to circulating tumor cell clusters and the treatment of cancerMASSACHUSETTS GEN HOSPITAL·Filed 2020·Granted Aug 23, 2022·0 cites·2 claims
- 2571US10900083B2Methods and assays relating to circulating tumor cellsMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Jan 26, 2021·1 cites·9 claims
- 2671US2022098678A1Biomarkers of CancerMASSACHUSETTS GEN HOSPITAL·Filed 2021·Application pending·0 cites
- 2771US2023226039A1Method for treating gefitinib resistant cancerWYETH LLC·Filed 2022·Application pending·0 cites
- 2870US10301624B2Targeting human satellite II (HSATII)MASSACHUSETTS GEN HOSPITAL·Filed 2015·Granted May 28, 2019·1 cites·25 claims
- 2970US6258536B1Expression monitoring of downstream genes in the BRCA1 pathwayFiled 1998·Granted Jul 10, 2001·38 cites·32 claims
- 3069US2025270651A1Detection of met amplification to predict responsiveness of cancer to drugsMASSACHUSETTS GEN HOSPITAL·Filed 2025·Application pending·0 cites
- 3168US12331363B2Digital analysis of blood samples to determine efficacy of cancer therapies for specific cancersMASSACHUSETTS GEN HOSPITAL·Filed 2022·Granted Jun 17, 2025·0 cites·15 claims
- 3266US11142800B2Biomarkers of cancerMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted Oct 12, 2021·0 cites·11 claims
- 3365US2021130910A1Methods and assays relating to circulating tumor cellsMASSACHUSETTS GEN HOSPITAL·Filed 2020·Application pending·0 cites
- 3465US2020032353A1Detection of met amplification to predict responsiveness of cancer to drugsMASSACHUSETTS GEN HOSPITAL·Filed 2019·Application pending·0 cites
- 3563US12381012B2Clinical predictive analytics systemBATTELLE MEMORIAL INSTITUTE·Filed 2021·Granted Aug 5, 2025·0 cites·20 claims
- 3661US10094837B2Cadherins as cancer biomarkersMASSACHUSETTS GEN HOSPITAL·Filed 2016·Granted Oct 9, 2018·0 cites·16 claims
- 3759US10000815B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsMASSACHUSETTS GEN HOSPITAL·Filed 2015·Granted Jun 19, 2018·0 cites·32 claims
- 3859US2014031250A1Biomarkers of CancerTING DAVID TSAI·Filed 2011·Application pending·0 cites
- 3958US11079383B2Diagnosis and monitoring treatment of prostate cancerMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted Aug 3, 2021·0 cites·11 claims
- 4058US2014287956A1Biomarkers of CancerGEN HOSPITAL CORP·Filed 2012·Application pending·0 cites
- 4157US8652786B2Method for predicting responsiveness to drugsHABER DANIEL A·Filed 2006·Granted Feb 18, 2014·1 cites·3 claims
- 4256US9766244B2Diagnosis and monitoring treatment of prostate cancerMASSACHUSETTS GEN HOSPITAL·Filed 2013·Granted Sep 19, 2017·0 cites·8 claims
- 4356US2017292942A1Biomarkers of CancerMASSACHUSETTS GEN HOSPITAL·Filed 2017·Application pending·0 cites
- 4455US2018057889A1Digital Analysis of Circulating Tumor Cells in Blood SamplesMASSACHUSETTS GEN HOSPITAL·Filed 2016·Application pending·0 cites
- 4554US2014162277A1Method for predicting responsiveness to drugsGEN HOSPITAL CORP·Filed 2013·Application pending·0 cites
- 4654US2011306043A1Devices and methods for enrichment and alteration of circulating tumor cells and other particlesFUCHS MARTIN·Filed 2009·Application pending·0 cites
- 4752US2001051339A1Expression monitoring of downstream genes in the BRCA1 pathwayFiled 2001·Application pending·0 cites
- 4852US2015112710A1Clinical predictive analytics systemBATTELLE MEMORIAL INSTITUTE·Filed 2014·Application pending·0 cites
- 4950US2005089858A1Salvador tumor suppressor geneFiled 2002·Application pending·0 cites
- 5048US2007099207A1Devices and methods for enrichment and alteration of circulating tumor cells and other particlesFUCHS MARTIN·Filed 2006·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Daniel A. Haber files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →